Books
Public Health Perspective on Intellectual Property and Access to Medicines
A compilation of studies prepared for WHO
South Centre, Geneva, 2016
Author: Carlos M. Correa
A compilation of studies prepared for WHO
South Centre, Geneva, 2016
Author: Carlos M. Correa
The WHO “Red Book” on Access to Medicines and Intellectual Property – 20 Years Later
South Centre, Geneva, 2015
Authors: Germán Velásquez & Pascale Boulet
South Centre, Geneva, 2015
Authors: Germán Velásquez & Pascale Boulet
Some Critical Issues Related to Access to Medicines and Intellectual Property
South Centre, Geneva, 2014
Author: Germán Velásquez
South Centre, Geneva, 2014
Author: Germán Velásquez
Policy Briefs
The US-Mexico-Canada Agreement: Putting Profits Before Patients
Policy Brief 61, May 2019
Maria Fabiana Jorge
Policy Brief 61, May 2019
Maria Fabiana Jorge
The ‘obvious to try’ method of addressing strategic patenting: How developing countries can utilise patent law to facilitate access to medicines
Policy Brief 59, April 2019
Olga Gurgula
Policy Brief 59, April 2019
Olga Gurgula
Will the Amendment to the TRIPS Agreement Enhance Access to Medicines?
Policy Brief 57, January 2019
Carlos M. Correa
Policy Brief 57, January 2019
Carlos M. Correa
Research Papers
Access to Medicines: Experiences with Compulsory Licenses and Government Use – The case of Hepatitis C
Research Paper 85, April 2019
Carlos M. Correa and Germán Velásquez
Research Paper 85, April 2019
Carlos M. Correa and Germán Velásquez
Compulsory Licensing Jurisprudence in South Africa: Do We Have Our Priorities Right?
Research Paper 90, December 2018
Yousuf A Vawda
Research Paper 90, December 2018
Yousuf A Vawda
Acceso a medicamentos: experiencias con licencias obligatorias y uso gubernamental – el caso de la Hepatitis C
Documento de Investigación 85, Mayo 2018
Germán Velásquez
Documento de Investigación 85, Mayo 2018
Germán Velásquez